- Vera's IgAN approval kicks off competition with OtsukaVera Therapeutics’ fusion protein atacicept got an accelerated approval on Tuesday for a chronic autoimmune disease that damages the kidneys. The drug will be marketed as Trutakna for immunoglobu…Endpoints · 19d ago↗ source
- STAT+: FDA approves Vera Therapeutics kidney disease treatmentThe FDA approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease.STAT · 19d ago↗ source
- STAT+: The crumbling employer-based health insurance systemToday's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance.STAT · 19d ago↗ source